On 7 and 8 July 2026, the Numantec Group will take part in the 14th NIVAS Congress, one of the UK’s leading events dedicated to vascular access and infusion therapy, held at the Hilton Brighton Metropole in Brighton.
Organised by the National Infusion and Vascular Access Society (NIVAS), the congress provides an important forum for healthcare professionals, scientific societies, companies and industry specialists to meet, with the aim of promoting the advancement of clinical practice and encouraging discussion of the latest scientific evidence.
NIVAS 2026: Shared Standards to Improve Clinical Practice
The 2026 edition of the congress will focus on the theme “Standardising Excellence”, with a programme centred on the implementation of shared national standards for vascular access management and infusion therapy.
Over the course of the two-day event, participants will explore the key topics currently shaping the evolution of clinical practice, including:
- new national standards for vascular access and infusion therapy;
- updated clinical guidelines and protocols;
- evidence-based practices;
- new vascular access technologies and devices;
- improved clinical outcomes through process standardisation.
The congress will also provide numerous opportunities for professionals from different disciplines to exchange views, share experiences, network and engage with companies operating in the sector.
Numantec at the 14th NIVAS Congress 2026
At the 2026 NIVAS Congress, Numantec will exhibit at Stand 20, where the Group will showcase its portfolio of vascular access and infusion therapy solutions.
The two-day NIVAS event provides an important opportunity to share expertise, engage with the UK and international markets, and showcase a comprehensive portfolio of solutions designed to support every stage of the clinical pathway.
The main technologies on display will include:
- cateteri venosi periferici (PIVC);
- sistemi a circuito chiuso (Closed System);
- Mini Midline;
- Long Cannula;
- Midline;
- PICC;
- Port;
- cateteri per emodialisi;
- accessi arteriosi corti e lunghi.
- peripheral intravenous catheters (PIVCs);
- closed-system devices;
- Mini Midlines;
- Long Cannulas;
- Midlines;
- PICCs;
- Ports;
- haemodialysis catheters;
- short and long arterial access devices.
Alongside the vascular access devices, Numantec will also showcase solutions for the day-to-day management of infusion therapy, including prefilled saline syringes for catheter flushing, prefilled citrate syringes in different concentrations for catheter locking, introducer kits, maintenance kits, DualCap® disinfection caps, elastomeric pumps and dedicated infusion therapy accessories.
An International Exchange to Drive Continued Innovation
Numantec’s participation in the 14th NIVAS Congress reaffirms the Group’s commitment to engaging with the international scientific community and developing solutions that reflect the evolving needs of clinical practice.
Taking part in a highly specialised event such as the NIVAS Congress provides an opportunity to contribute to discussions on emerging perspectives in vascular access, highlight the value of technological innovation and strengthen relationships with professionals and partners who work every day to improve care pathways.
Further information about the congress is available on the official website official website.
